Ajanta Pharma launches BP lowering tablets in US

NEW DELHI: Drug firm Ajanta Pharma today said it has launched blood pressure lowering tablet in the US market.

After the approval of the United States Food and Drug Administration (USFDA), the company has launched Amlodipine + Olmesartan Medoxomil tablets in the US market through its arm Ajanta Pharma USA Inc," the company said in a BSE filing today.

The company's product is a generic version of Daiichi Sankyo Inc's Azor tablets, it added.


The product has been launched in four strengths 5mg+20mg, 5mg+40mg, 10mg+20mg and 10mg+40mg, Ajanta Pharma said.

"Amlodipine + Olmesartan Medoxomil tablets is part of an ever growing portfolio of products that Ajanta has developed for the US market," it added.

In total, the company has 29 Abbreviated New Drug Applications (ANDA) of which 16 are final ANDA approvals, 2 tentative approvals and 11 ANDAs are under review with USFDA, Ajanta Pharma said.

Shares of the company today closed 1.84 per cent down at Rs 1,960.35 apiece on BSE.